Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer.
Belladelli F, De Cobelli F, Piccolo C, Cei F, Re C, Musso G, Rosiello G, Cignoli D, Santangelo A, Fallara G, Matloob R, Bertini R, Gusmini S, Brembilla G, Lucianò R, Tenace N, Salonia A, Briganti A, Montorsi F, Larcher A, Capitanio U. Belladelli F, et al. Among authors: bertini r. Urol Oncol. 2024 Nov 7:S1078-1439(24)00700-2. doi: 10.1016/j.urolonc.2024.10.020. Online ahead of print. Urol Oncol. 2024. PMID: 39516081
How to Select the Optimal Candidates for Renal Mass Biopsy.
Martini A, Larcher A, Bravi CA, Capogrosso P, Falagario UG, Fallara G, Pellegrino F, Muttin F, Re C, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U; Young Academic Urologists working groups on robotic surgery and kidney cancer of the European Association of Urology. Martini A, et al. Among authors: bertini r. Eur Urol Oncol. 2021 Jun;4(3):506-509. doi: 10.1016/j.euo.2020.10.001. Epub 2020 Oct 21. Eur Urol Oncol. 2021. PMID: 34074486
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer.
Cei F, Larcher A, Rosiello G, Basile G, Musso G, Re C, Fallara G, Belladelli F, Brembilla G, Guazzarotti G, De Cobelli F, Marandino L, Necchi A, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U. Cei F, et al. Among authors: bertini r. Urol Oncol. 2024 Aug;42(8):247.e21-247.e27. doi: 10.1016/j.urolonc.2024.01.029. Epub 2024 Apr 21. Urol Oncol. 2024. PMID: 38644109
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.
Rosiello G, Larcher A, Fallara G, Giancristofaro C, Martini A, Re C, Cei F, Musso G, Tian Z, Karakiewicz PI, Mottrie A, Bertini R, Salonia A, Necchi A, Raggi D, Briganti A, Montorsi F, Capitanio U. Rosiello G, et al. Among authors: bertini r. Urol Oncol. 2022 Jun;40(6):271.e19-271.e27. doi: 10.1016/j.urolonc.2021.12.010. Epub 2022 Feb 6. Urol Oncol. 2022. PMID: 35140049
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R. Abdollah F, et al. Among authors: bertini r. Urol Oncol. 2014 Jan;32(1):43.e9-16. doi: 10.1016/j.urolonc.2013.05.006. Epub 2013 Aug 2. Urol Oncol. 2014. PMID: 23911684
Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer.
Capitanio U, Larcher A, Cianflone F, Trevisani F, Nini A, Mottrie A, Mari A, Campi R, Tellini R, Briganti A, Veccia A, Van Poppel H, Carini M, Simeone C, Salonia A, Minervini A, Antonelli A, Montorsi F, Bertini R. Capitanio U, et al. Among authors: bertini r. Eur Urol Oncol. 2020 Apr;3(2):209-215. doi: 10.1016/j.euo.2019.02.006. Epub 2019 Mar 25. Eur Urol Oncol. 2020. PMID: 31411993
217 results